These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 24403508)

  • 1. Collateral sensitivity to cisplatin in KB-8-5-11 drug-resistant cancer cells.
    Doherty B; Lawlor D; Gillet JP; Gottesman M; O'Leary JJ; Stordal B
    Anticancer Res; 2014 Jan; 34(1):503-7. PubMed ID: 24403508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Copper efflux transporter (ATP7B) contributes to the acquisition of cisplatin-resistance in human oral squamous cell lines.
    Yoshizawa K; Nozaki S; Kitahara H; Ohara T; Kato K; Kawashiri S; Yamamoto E
    Oncol Rep; 2007 Oct; 18(4):987-91. PubMed ID: 17786364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic Targeting of ATP7B in Ovarian Carcinoma.
    Mangala LS; Zuzel V; Schmandt R; Leshane ES; Halder JB; Armaiz-Pena GN; Spannuth WA; Tanaka T; Shahzad MM; Lin YG; Nick AM; Danes CG; Lee JW; Jennings NB; Vivas-Mejia PE; Wolf JK; Coleman RL; Siddik ZH; Lopez-Berestein G; Lutsenko S; Sood AK
    Clin Cancer Res; 2009 Jun; 15(11):3770-80. PubMed ID: 19470734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of vinorelbine on cisplatin resistance reversal in human lung cancer A549/DDP cells.
    Zhou YT; Li K; Tian H
    Asian Pac J Cancer Prev; 2013; 14(8):4635-9. PubMed ID: 24083716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression analysis of genes involved in oxaliplatin response and development of oxaliplatin-resistant HT29 colon cancer cells.
    Plasencia C; Martínez-Balibrea E; Martinez-Cardús A; Quinn DI; Abad A; Neamati N
    Int J Oncol; 2006 Jul; 29(1):225-35. PubMed ID: 16773204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment and biological analysis of the EC109/CDDP multidrug-resistant esophageal squamous cell carcinoma cell line.
    Wen J; Zheng B; Hu Y; Zhang X; Yang H; Luo KJ; Zhang X; Li YF; Fu JH
    Oncol Rep; 2009 Jul; 22(1):65-71. PubMed ID: 19513506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of chemoresistance mechanisms in a series of cisplatin-resistant transitional carcinoma cell lines.
    Hour TC; Chen J; Huang CY; Guan JY; Lu SH; Hsieh CY; Pu YS
    Anticancer Res; 2000; 20(5A):3221-5. PubMed ID: 11062746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of copper-transporting P-type adenosine triphosphatase (ATP7B) correlates with cisplatin resistance in human non-small cell lung cancer xenografts.
    Nakagawa T; Inoue Y; Kodama H; Yamazaki H; Kawai K; Suemizu H; Masuda R; Iwazaki M; Yamada S; Ueyama Y; Inoue H; Nakamura M
    Oncol Rep; 2008 Aug; 20(2):265-70. PubMed ID: 18636185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cisplatin sensitivity of oral squamous carcinoma cells is regulated by Na+,K+-ATPase activity rather than copper-transporting P-type ATPases, ATP7A and ATP7B.
    Ahmed Z; Deyama Y; Yoshimura Y; Suzuki K
    Cancer Chemother Pharmacol; 2009 Mar; 63(4):643-50. PubMed ID: 18545997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Copper-transporting P-type adenosine triphosphatase (ATP7B) as a cisplatin based chemoresistance marker in ovarian carcinoma: comparative analysis with expression of MDR1, MRP1, MRP2, LRP and BCRP.
    Nakayama K; Kanzaki A; Ogawa K; Miyazaki K; Neamati N; Takebayashi Y
    Int J Cancer; 2002 Oct; 101(5):488-95. PubMed ID: 12216079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Copper-transporting P-type adenosine triphosphatase (ATP7B) is associated with cisplatin resistance.
    Komatsu M; Sumizawa T; Mutoh M; Chen ZS; Terada K; Furukawa T; Yang XL; Gao H; Miura N; Sugiyama T; Akiyama S
    Cancer Res; 2000 Mar; 60(5):1312-6. PubMed ID: 10728692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hedgehog signaling regulates drug sensitivity by targeting ABC transporters ABCB1 and ABCG2 in epithelial ovarian cancer.
    Chen Y; Bieber MM; Teng NN
    Mol Carcinog; 2014 Aug; 53(8):625-34. PubMed ID: 23423781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance to paclitaxel in a cisplatin-resistant ovarian cancer cell line is mediated by P-glycoprotein.
    Stordal B; Hamon M; McEneaney V; Roche S; Gillet JP; O'Leary JJ; Gottesman M; Clynes M
    PLoS One; 2012; 7(7):e40717. PubMed ID: 22792399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of genes of glutathione transferase isoforms GSTP1-1, GSTA4-4, and GSTK1-1 in tumor cells during the formation of drug resistance to cisplatin.
    Kalinina EV; Berozov TT; Shtil AA; Chernov NN; Glasunova VA; Novichkova MD; Nurmuradov NK
    Bull Exp Biol Med; 2012 Nov; 154(1):64-7. PubMed ID: 23330092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Copper-transporting P-type adenosine triphosphatase (ATP7B) is expressed in human breast carcinoma.
    Kanzaki A; Toi M; Neamati N; Miyashita H; Oubu M; Nakayama K; Bando H; Ogawa K; Mutoh M; Mori S; Terada K; Sugiyama T; Fukumoto M; Takebayashi Y
    Jpn J Cancer Res; 2002 Jan; 93(1):70-7. PubMed ID: 11802810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-133a enhances the sensitivity of Hep-2 cells and vincristine-resistant Hep-2v cells to cisplatin by downregulating ATP7B expression.
    Wang X; Zhu W; Zhao X; Wang P
    Int J Mol Med; 2016 Jun; 37(6):1636-42. PubMed ID: 27121102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-495 enhances the sensitivity of non-small cell lung cancer cells to platinum by modulation of copper-transporting P-type adenosine triphosphatase A (ATP7A).
    Song L; Li Y; Li W; Wu S; Li Z
    J Cell Biochem; 2014 Jul; 115(7):1234-42. PubMed ID: 24038379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression profile of copper transporters in sensitive and cisplatin/oxaliplatin-resistant tumor cell lines.
    Kassack MU; Stratenschulte C
    Int J Clin Pharmacol Ther; 2005 Dec; 43(12):597-8. PubMed ID: 16372532
    [No Abstract]   [Full Text] [Related]  

  • 19. Factors affecting sensitivity to antitumor platinum derivatives of human colorectal tumor cell lines.
    Kitada N; Takara K; Minegaki T; Itoh C; Tsujimoto M; Sakaeda T; Yokoyama T
    Cancer Chemother Pharmacol; 2008 Sep; 62(4):577-84. PubMed ID: 18030470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-133b targets glutathione S-transferase π expression to increase ovarian cancer cell sensitivity to chemotherapy drugs.
    Chen S; Jiao JW; Sun KX; Zong ZH; Zhao Y
    Drug Des Devel Ther; 2015; 9():5225-35. PubMed ID: 26396496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.